We are a small, growing charity run by and for amyloidosis patients. We aim to bring the amyloidosis community together and to provide information and support to anyone living in the UK who is affected by amyloidosis.

ARC is accelerating the development of and access to new and innovative treatments for systemic #amyloidosis

Doudna Lab at UC Berkeley, Innovative Genomics Institute founder, CRISPR co-inventor and Nobel laureate innovativegenomics.org/

We're a #GeneEditing company, developing novel, potentially curative therapeutics leveraging #CRISPR-based technologies. Guidelines: http://ow.ly/CHPD30iXX1p

Intellia Therapeutics

Amyloidosis UK

Amyloidosis Research Consortium

Jennifer Doudna